Friday, October 2, 2026
25.3 C
Bengaluru

FLUX – Indian Pharma in the Post VUCA World

Introduction

For decades, leaders and organizations have relied on the VUCA framework—Volatility, Uncertainty, Complexity, and Ambiguity—to understand and respond to a turbulent world. Originally developed by the U.S. Army after the Cold War (Bennett & Lemoine, 2014), VUCA provided a language for confronting rapidly shifting geopolitical, economic, and technological landscapes. However, with the accelerating pace of AI advancements, digital transformation, and interconnected global crises, VUCA is no longer sufficient. A new framework, FLUX, has emerged to help leaders and organizations build adaptive capabilities in an AI-driven world.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

Topics

spot_img

Related Articles

spot_imgspot_img